Trial Profile
A Phase I Study Of 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (3-AP, Triapine) [OCX 0191] In Combination With Cisplatin And Paclitaxel In Patients With Advanced And Metastatic Cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Jul 2013
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; OCX 191 (Primary) ; Paclitaxel (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 02 Jan 2008 Status changed from in progress to completed.
- 29 Sep 2005 New trial record.